File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs

TitlePotential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs
Authors
KeywordsCoronavirus
QFPDT
Therapeutic Targets
Ephedra sinica
Bupleurum chinense
Issue Date2020
PublisherWorld Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/ajcm/ajcm.shtml
Citation
The American Journal of Chinese Medicine, 2020, v. 48 n. 5, p. 1051-1071 How to Cite?
AbstractCOVID-19 has been declared a pandemic by WHO on March 11, 2020. No specific treatment and vaccine with documented safety and efficacy for the disease have been established. Hence it is of utmost importance to identify more therapeutics such as Chinese medicine formulae to meet the urgent need. Qing Fei Pai Du Tang (QFPDT), a Chinese medicine formula consisting of 21 herbs from five classical formulae has been reported to be efficacious on COVID-19 in 10 provinces in mainland China. QFPDT could prevent the progression from mild cases and shorten the average duration of symptoms and hospital stay. It has been recommended in the 6th and 7th versions of Clinical Practice Guideline on COVID-19 in China. The basic scientific studies, supported by network pharmacology, on the possible therapeutic targets of QFPDT and its constituent herbs including Ephedra sinica, Bupleurum chinense, Pogostemon cablin, Cinnamomum cassia, Scutellaria baicalensis were reviewed. The anti-oxidation, immuno-modulation and antiviral mechanisms through different pathways were collated. Two clusters of actions identified were cytokine storm prevention and angiotensin converting enzyme 2 (ACE2) receptor binding regulation. The multi-target mechanisms of QFPDT for treating viral infection in general and COVID-19 in particular were validated. While large scale clinical studies on QFPDT are being conducted in China, one should use real world data for exploration of integrative treatment with inclusion of pharmacokinetic, pharmacodynamic and herb-drug interaction studies.
Persistent Identifierhttp://hdl.handle.net/10722/284567
ISSN
2019 Impact Factor: 3.682
2015 SCImago Journal Rankings: 0.797

 

DC FieldValueLanguage
dc.contributor.authorZhong, LLD-
dc.contributor.authorLam, WC-
dc.contributor.authorYang, W-
dc.contributor.authorChan, KW-
dc.contributor.authorSze, SCW-
dc.contributor.authorMiao, J-
dc.contributor.authorYung, KKL-
dc.contributor.authorBian, Z-
dc.contributor.authorWong Taam, V-
dc.date.accessioned2020-08-07T08:59:28Z-
dc.date.available2020-08-07T08:59:28Z-
dc.date.issued2020-
dc.identifier.citationThe American Journal of Chinese Medicine, 2020, v. 48 n. 5, p. 1051-1071-
dc.identifier.issn0192-415X-
dc.identifier.urihttp://hdl.handle.net/10722/284567-
dc.description.abstractCOVID-19 has been declared a pandemic by WHO on March 11, 2020. No specific treatment and vaccine with documented safety and efficacy for the disease have been established. Hence it is of utmost importance to identify more therapeutics such as Chinese medicine formulae to meet the urgent need. Qing Fei Pai Du Tang (QFPDT), a Chinese medicine formula consisting of 21 herbs from five classical formulae has been reported to be efficacious on COVID-19 in 10 provinces in mainland China. QFPDT could prevent the progression from mild cases and shorten the average duration of symptoms and hospital stay. It has been recommended in the 6th and 7th versions of Clinical Practice Guideline on COVID-19 in China. The basic scientific studies, supported by network pharmacology, on the possible therapeutic targets of QFPDT and its constituent herbs including Ephedra sinica, Bupleurum chinense, Pogostemon cablin, Cinnamomum cassia, Scutellaria baicalensis were reviewed. The anti-oxidation, immuno-modulation and antiviral mechanisms through different pathways were collated. Two clusters of actions identified were cytokine storm prevention and angiotensin converting enzyme 2 (ACE2) receptor binding regulation. The multi-target mechanisms of QFPDT for treating viral infection in general and COVID-19 in particular were validated. While large scale clinical studies on QFPDT are being conducted in China, one should use real world data for exploration of integrative treatment with inclusion of pharmacokinetic, pharmacodynamic and herb-drug interaction studies.-
dc.languageeng-
dc.publisherWorld Scientific Publishing Co Pte Ltd. The Journal's web site is located at http://www.worldscinet.com/ajcm/ajcm.shtml-
dc.relation.ispartofThe American Journal of Chinese Medicine-
dc.subjectCoronavirus-
dc.subjectQFPDT-
dc.subjectTherapeutic Targets-
dc.subjectEphedra sinica-
dc.subjectBupleurum chinense-
dc.titlePotential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs-
dc.typeArticle-
dc.identifier.emailChan, KW: chriskwc@hku.hk-
dc.identifier.emailWong Taam, V: vcwwong@hku.hk-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1142/S0192415X20500512-
dc.identifier.pmid32668969-
dc.identifier.scopuseid_2-s2.0-85088155901-
dc.identifier.hkuros311553-
dc.identifier.volume48-
dc.identifier.issue5-
dc.identifier.spage1051-
dc.identifier.epage1071-
dc.publisher.placeSingapore-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats